Results

1–10 of 12 results for biomarkers

Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy
Judy E. Kim, MD, FASRS
Chirag D. Jhaveri, MD, FASRS
Michael S. Ip, MD
Arshad M. Khanani, MD, MA, FASRS
Jordana G Fein, MD, MS
Dennis M. Marcus, MD
Diana V Do, MD, FASRS
Annual Meeting Talks
2024
Diabetic Retinopathy Lesion Types and Distribution on Ultra-Widefield Imaging and the Risk for Disease Worsening Over Time
Paolo Antonio S. Silva, MD
Annual Meeting Talks
2024
OCT Biomarkers for Surgical Retinal Disorders
Srinivas Reddy Sadda, MD
Updates from the Field
2025
Biomarkers in the Vitreous Humor Correlate With Alzheimer’s Disease and Chronic Traumatic Encephalopathy in Postmortem Eyes and Brain
Manju L. Subramanian, MD
Annual Meeting Talks
2022
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2021
Evaluation of Nonperfusion Area and Other Vascular Metrics by Widefield SS-OCTA as Biomarkers of Diabetic Retinopathy Severity
John B. Miller, MD
Annual Meeting Talks
2021
Predictive Modeling of Proliferative Diabetic Retinopathy and DME Based on Analysis of High-Value Biomarkers
Kameran Lashkari, MD, FASRS
On Demand Cases, Courses, and Papers
2019
Optical Coherence Tomography Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema
Yi-Ting Hsieh, MD
On Demand Cases, Courses, and Papers
2019
Retinal Biomarkers of Alzheimer's Disease with Drs. Cecilia Lee and Rajendra Apte
Keyvan Koushan, MD, FRCSC
Rajendra S. Apte, MD, PhD
Cecilia S Lee, MD
Member Podcasts
2020
Biomarkers and Predictors for Functional and Anatomical Outcomes for Small Gauge Pars Plana Vitrectomy and Peeling of the ILM in Naive DME
Matias Iglicki, MD
Annual Meeting Talks